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Abstract
The aim of this study was to characterize the urine metabolome of women with Chlamydia
trachomatis (CT) uro-genital infection (n = 21), comparing it with a group of CT-negative
subjects (n = 98). By means of a proton-based nuclear magnetic resonance (1H-NMR) spec-
troscopy, we detected and quantified the urine metabolites of a cohort of 119 pre-meno-
pausal Caucasian women, attending a STI Outpatients Clinic in Italy. In case of a CT
positive result, CT molecular genotyping was performed by omp1 gene semi-nested PCR
followed by RFLP analysis. We were able to identify several metabolites whose concentra-
tions were significantly higher in the urine samples of CT-positive subjects, including
sucrose, mannitol, pyruvate and lactate. In contrast, higher urinary levels of acetone repre-
sented the main feature of CT-negative women.
These results were not influenced by the age of patients nor by the CT serovars (D, E, F,
G, K) responsible of the urethral infections. Since the presence of sugars can increase the
stability of chlamydial proteins, higher levels of sucrose and mannitol in the urethral lumen,
related to a higher sugar consumption, could have favoured CT infection acquisition or
could have been of aid for the bacterial viability. Peculiar dietary habits of the subjects
enrolled, in term of type and amount of food consumed, could probably explain these find-
ings. Lactate and pyruvate could result from CT-induced immunopathology, as a product of
the inflammatory microenvironment. Further studies are needed to understand the potential
role of these metabolites in the pathogenesis of CT infection, as well as their diagnostic/
prognostic use.
Introduction
Chlamydia trachomatis (CT) represents the agent of the most common bacterial sexually trans-
mitted infection (STI) worldwide, with more than 100 million new cases per year [1].
In women, uro-genital CT infections (i.e. urethritis, cervicitis) are often asymptomatic and,
if left untreated, can lead to several complications and sequelae including pelvic inflammatory
disease, tubal infertility and ectopic pregnancy [2].
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CT is an obligate intracellular pathogen, showing a unique cycle of development with two
distinct bacterial forms. The elementary bodies (EBs), infectious but non-dividing, enter epi-
thelial cells and differentiate into reticulate bodies (RBs). After several rounds of replication by
binary fission, RBs differentiate back into EBs and are released from the host cell 48–72 hours
post-infection, ready to infect neighboring cells [3].
This development cycle requires a highly-regulated expression of chlamydial stage-specific
genes and can be influenced by several environmental factors, as nutrient deprivation and
exposure to host cytokines and antibiotics. In addition, chlamydiae modulate the host cell
cycle progression and can cause substantial changes in gene expression and protein produc-
tion in the host, at the transcriptional, translational and post-translational levels [3].
In this context, several in-vitro studies have investigated the metabolic adaptation of CT to
mammalian host cells, as well as its stage-specific metabolic and transcriptional activity [4–6].
However, to the best of our knowledge, no data are available about the metabolic profile that
can be found in human biological fluids during an ongoing CT infection.
The aim of this study was therefore to characterize the urine metabolome of women with
CT uro-genital infection, comparing it with a group of CT-negative subjects. In particular, by
means of a proton-based nuclear magnetic resonance (1H-NMR) spectroscopy, we detected
and quantified the urine low weight metabolites of a cohort of 119 pre-menopausal Caucasian
women, attending a STI Outpatients Clinic. 1H-NMR spectroscopy is a primary analytical
technique used for metabolite detection, able to determine a molecular structure by measuring
nuclear chemical shifts within a magnetic field [7]. In the recent past, such approach has been
found useful to evidence consequences of inflammatory processes [8] and food habits [9, 10],
thus appearing as promising in the present context.
Materials and methods
Study population and sample collection
From January 2016 to July 2016, all the pre-menopausal non-pregnant Caucasian women
attending the STI Outpatients Clinic of Sant’Orsola-Malpighi Hospital in Bologna (Italy) and
meeting one of the following criteria were enrolled: presence of uro-genital symptoms (i.e. vag-
inal discharge, dysuria, abnormal bleeding, dyspareunia) and/or presence of risk factors for
CT infection (age < 25 years, new or multiple sexual partners, unsafe intercourses). Exclusion
criteria comprised the use of any drugs or medications in the past month, the presence of
chronic diseases and major endocrine or gynaecologic pathologies.
For all the patients, demographic data, behavioural characteristics and information about
uro-genital symptoms were recorded. A written consent was obtained by all the patients and
the study protocol was reviewed and approved by the Ethics committee of St. Orsola-Malpighi
Hospital (7/2016/U/Tess).
Each enrolled subject provided the first void of the first urines of the morning. Then, after
the interview and a clinical examination, a vaginal swab was collected by a clinician. The urine
specimens were split within 3 hours of collection: 2.5 mL were used for CT, Neisseria gonor-
rhoeae Trichomonas vaginalis and Mycoplasma genitalium detection by commercial nucleic
acid amplification techniques (NAATs) (Versant CT/GC DNA 1.0 Assay; Siemens Healthi-
neers, Terrytown, NY, USA; Aptima Trichomonas vaginalis and Aptima Mycoplasma genita-
lium assay, Panther system, Hologic, Marlborough, MA, USA, respectively), whereas, 1 mL
was frozen at –20˚C. These specimens were kept frozen for a maximum of 1 month, prior to
the 1H-NMR analysis and they were thawed only at the time of the metabolomic analysis, as
described below.
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The vaginal swab (E-swab, Copan, Brescia, Italy) was used for the molecular detection of
CT, N. gonorrhoeae, T. vaginalis and M. genitalium, for the microscopic and culture-based
diagnosis of candidiasis and aerobic vaginitis, as well as for bacterial vaginosis assessment
(Nugent score> 7) [11].
Eligible women were allocated in one of the two following groups according on CT positiv-
ity (CT -positive group) or negativity (CT-negative group) in both the uro-genital tested sites.
CT genotyping
In case of a CT positive result, the correspondent remaining eluate was recovered from Ver-
sant PCR plate and used for CT molecular genotyping [12]. Molecular genotyping was per-
formed by omp1 gene semi-nested PCR followed by RFLP analysis, as previously described
[13, 14]. Briefly, the first product of 1033 base pairs (bp) was amplified using the following
paired primers: SERO1A (5’-ATGAAAAAACTCTGAAATCGG-3’) and SERO2A (5’-TTT
CTAGATCTTCATTCTTGTT-3’). Then, 1 μL of the first-round PCR product was used to
amplify a 978 bp fragment, using the following primers: SERO2A and PCTM3 (5’-TCCTT
GCAAGCTCTGCCTGTGGGGAATCCT-3’). After the PCR step, the amplified product was
digested with AluI, DdeI and/or HinfI as restriction enzymes (Promega, Madison, USA) and
visualized after electrophoresis run in ethidium bromide stained 12% polyacrylamide gel. CT
serovar identification was achieved by the analysis of the specific restriction pattern.
Urine metabolome analysis by 1H-NMR
The general workflow of urine metabolome analysis by means of 1H-NMR is illustrated in Fig
1. Urine samples were prepared for 1H-NMR analysis by thawing them right before analysis.
After centrifugation for 15 min at 18630 g at 4˚C, an amount of supernatant equal to 700 μL
was added to 200 μL of a D2O solution of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid (TSP)
sodium salt 10 mM, buffered at pH 7.00 ± 0.02 by means of 1M phosphate buffer. The pH of
each sample was then finely adjusted to pH 7.00 ± 0.02 by the addition of a few drops of NaOH
(1 M). 1H-NMR spectra were recorded at 298 K with an AVANCE III spectrometer (Bruker,
Milan, Italy) operating at a frequency of 600.13 MHz, equipped with Topspin software (Ver.
3.5).
The residual water signal was suppressed by applying the first increment of the nuclear
Over-hauser effect spectroscopy (NOESY) pulse sequence and a spoil gradient. This was done
by employing the NOESYGPPR1D sequence, part of the standard pulse sequence library. Each
spectrum was acquired using 32,000 data points over a 7,211.54 Hz spectral width and adding
256 transients. A recycle delay of 5 s and a 90˚ pulse of 11.4 μs were set up.
Acquisition time (2.28 s) and recycle delay were adjusted to be 5 times longer than the lon-
gitudinal relaxation time of the protons under investigation, which was considered to be not
longer than 1.4 s.
To each spectrum, line broadening (0.3 Hz) and phase adjustment was applied by Topspin
software, while any further spectra processing, molecules quantification and data mining step
was performed in R computational language (R: A Language and Environment for Statistical
Computing) by means of scripts developed in house.
The spectra were aligned towards the right peak of alanine doublet, set to 1.473 ppm, and
the signals of water and urea were removed. The spectra were then baseline-adjusted by means
of peak detection according to the “rolling ball” principle [15] implemented in the “baseline” R
package [16]. A linear correction was then applied to each spectrum, so to make the points per-
taining to the baseline randomly spread around zero. No manual alignment of the signals was
necessary, differently from previous investigations [8].
Chlamydia trachomatis and urine metabolome
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The signals were assigned by comparing their chemical shift and multiplicity with the
Human Metabolome Database [17] and the compounds library (Ver. 10) of Chenomx software
(Chenomx Inc., Canada, Ver. 8.3). Quantification of the molecules was performed in the first
sample acquired by employing the added TSP as an internal standard. In order to compensate
for differences in solids content, any other sample was then normalized to such sample by
means of probabilistic quotient normalization [18], set up so to exclude spectra portions
ascribed to water and urea. Integration of the signals was performed for each molecule by
means of rectangular integration.
Statistical analysis
All statistical analysis were performed by using R computational language. In order to evaluate
statistically significant differences between the two groups of subjects, Wilcoxon test was used
to compare quantitative data, while categorical data were analyzed with Fisher’s exact test. Dif-
ferences in urine metabolites between groups were calculated by means of a two-tailed
unpaired Wilcoxon test. Interactions among variables (i.e. the age of patients and metabolite
concentrations) on metabolome features were analyzed, by expressing the concentration of
each molecules as ranks, followed by two-way ANOVA, as previously suggested [19].
In order to summarize the information from univariate analysis, robust principal compo-
nent analysis (rPCA) [20] has been chosen as the election chemometric technique. Principal
component analysis algorithm rotates the original space represented by the concentration of
each molecule, so to show the samples from the point of view representing the greatest per-
centage of the samples’ variance. The scoreplot, the representation of the samples from the
new point of view, helps to visually inspect the trends underlying the samples, while the loa-
dingplot (barplot) evidences the molecules mainly driving the trends. Statistical significance
was determined at P< 0.05.
Results
Study group
During the study period, a total of 119 subjects met the inclusion criteria and were enrolled. In
particular, 98 women were allocated in the CT-negative group, whereas 21 showed a contem-
porary positivity for CT both on urines and on the vaginal swab and were assigned to the CT-
positive group. Clinical, behavioural and demographic information of the study groups are
reported in details in Table 1.
Notably, more than half (12/21; 57.1%) of CT-positive patients were completely asymptom-
atic. In case of symptoms, they complained about the presence of dyspareunia (6/9) and vagi-
nal discharge (5/9) and less frequently about abnormal bleeding (3/9) and dysuria (2/9).
The cohort of the 98 women of the CT-negative group included 20 patients with bacterial
vaginosis, 14 subjects with vulvo-vaginal candidiasis, 3 women with Mycoplasma genitalium
infection, 1 case of trichomoniasis and 60 women (50% with various uro-genital symptoms)
negative for all the microbiological tests performed. Patients with T. vaginalis and M.
Fig 1. Graphic design of the workflow for urines preparation and 1H-NMR spectra processing. Urine samples were centrifuged and
700 μl of the supernatant were added to 0.2 mL of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid (TSP) sodium salt 10 mM in deuterated
water. The pH values of the solutions were adjusted to 7.0 by means of NaOH 1M and the samples were subjected to 1H-NMR
spectroscopy. The spectra obtained by 1H-NMR were aligned and baseline-adjusted (normalization) and the signals were assigned to a
specific metabolite by comparing their chemical shift and multiplicity with dedicated databases and libraries. Quantification of the
molecules was achieved after the calculation of the area under each peak by means of a rectangular integration. The added TSP, at a known
concentration, was employed as internal standard.
https://doi.org/10.1371/journal.pone.0194827.g001
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genitalium infections were found positive only at the vaginal level, thus excluding an urethral
involvement.
CT genotyping
The most common CT serovar in our population was E (11/21; 52.4%) followed by F (3/21;
14.3%), G (3/21; 14.3%), D (2/21; 9.5%) and K (2/21; 9.5%). No significant associations
between CT serovar and the presence of symptoms were found.
Metabolome analysis
The urine samples were subjected to 1H-NMR spectroscopy in order to determine the meta-
bolic profiles in the different groups. By means of the metabolomic analysis, we detected and
quantified 66 molecules, mainly belonging to the groups of sugars, organic acids, nitrogen
compounds and amino acids (S1 Table). An example of a visual representation of the mole-
cules assignment and quantification procedure is depicted in S1 Fig.
By means of univariate analysis, differences in the metabolic profiles were searched between
CT-positive and CT-negative groups. Table 2 lists the metabolites whose concentration signifi-
cantly differed between the two. In particular, higher concentrations of 2-furoylglycine,
Table 2. Molecules whose concentration (mM, mean ± SD) showed significant differences (P<0.05) in relation to Chlamydia trachomatis positivity. CT-: C. tracho-
matis-negative; CT+: C. trachomatis-positive.
CT- CT+ P
Hypoxanthine 1.48E-1 ± 1.91E-1 8.92E-2 ± 4.97E-2 0.01
2-Furoylglycine 9.08E-2 ± 1.05E-1 1.39E-1 ± 1.19E-1 0.03
Sucrose 6.79E-2 ± 5.63E-2 2.37E-1 ± 6.46E-2 < 0.0001
Threonine 2.04E-1 ± 7.22E-2 2.38E-1 ± 6.47E-2 0.03
Lactate 3.02E-1 ± 3.82E-1 3.48E-1 ± 1.20E-1 0.002
Mannitol 2.20 ± 2.66 2.65 ± 1.72 0.003
Methylguanidine 4.66E-2 ± 2.57E-2 3.84E-2 ± 3.18E-2 0.01
Pyruvate 1.91E-2 ± 9.07E-3 3.62E-2 ± 5.89E-2 0.02
Acetone 4.78E-2 ± 2.59E-1 9.86E-3 ± 3.34E-3 0.01
Methylsuccinate 5.99E-2 ± 4.04E-2 7.80E-2 ± 3.56E-2 0.004
https://doi.org/10.1371/journal.pone.0194827.t002
Table 1. Demographic, behavioural and clinic characteristics of the women enrolled for the study.
CT negative CT positive P value
(n = 98) (n = 21)
Mean age ± SD (years) 28.6 ± 7.4 24.3 ± 3.6 0.01
Sexual orientation
-heterosexual 98/98 (100%) 21/21 (100%) -
-homosexual 0/98 (0%) 0/21 (100%) -
Previous STIs
-syphilis 12/98 (12.2%) 3/21 (14.2%) 0.72
-urogenital CT infection 17/98 (17.3%) 4/21 (19.0%) 1.0
-genital HPV 7/98 (7.1%) 1/21 (4.8%) 1.0
Partner positive for CT 2/98 (2.1%) 5/21 (23.8%) 0.002
Symptoms
-genital symptoms 59/98 (60.2%) 9/21 (42.8%) 0.15
-urethral symptoms 11/98 (11.2%) 2/21 (9.5%) 1.0
https://doi.org/10.1371/journal.pone.0194827.t001
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sucrose, threonine, methylsuccinate, lactate, mannitol and pyruvate were found in CT-positive
subjects, whereas CT-negative patients were characterized by higher levels of acetone, hypoxan-
thine and methylguanidine. The range of concentrations of these metabolites were in line with pre-
vious reports, evaluating the urinary levels in healthy adults (S2 Table). These data can be found on
the ‘human metabolome database’ (HMDB; www.hmdb.ca), a freely available electronic database
containing detailed information about small molecule metabolites found in the human body.
Considering that CT-infected women were significantly younger than CT-negative ones,
we wondered if the age of the patients was a confounding factor on the effects of chlamydia on
metabolomic profiles. By means of a two way ANOVA, we excluded that age exerted any influ-
ence on the urine metabolome of the two study groups.
In order to highlight underlying trends in the metabolome subspace represented by these
molecules, their concentration was employed as a base for the calculation of a robust principal
component analysis (rPCA) model (Fig 2).
Six components were found to describe robustly the samples. PC1, explaining the 38.3% of
the total variance, effectively accounted for the presence of C. trachomatis infection, with CT-
negative subjects appearing at low PC1 scores and CT-positive ones characterized by high
value scores (P<0.001). The correlation between the concentration of each molecule and its
importance over PC1 served as a handy way to rank the molecules in order of importance in
determining such grouping, with high concentrations of sucrose and low concentrations of
acetone representing the main features of C. trachomatis presence.
The composition of urine metabolites did not vary significantly between the different CT
serovars responsible for the infections.
Discussion
In this study we characterized the metabolic profile of urine samples of two groups of pre-
menopausal women: 21 patients with uro-genital C. trachomatis infections and 98 CT-negative
Fig 2. rPCA model calculated on the space constituted by the concentration of the molecules listed in Table 1. In the scoreplot (A), CT-negative (CT-) and CT-
positive (CT+) subjects are represented in black and gray respectively, with lines connecting each subject to the median of its group. In the barplot (B), describing the
correlation between the concentration of each molecule and its importance over PC 1, dark gray bars highlight statistically significant correlations (P<0.05).
https://doi.org/10.1371/journal.pone.0194827.g002
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subjects. The relevance of a deep comprehension of the features of the urine metabolome in
CT-positive women lies in several aspects: (i) getting new insights in the pathogenesis of CT
urethral infections; (ii) identifying metabolites that may favor CT infection acquisition or per-
sistence; (iii) opening the perspective of new diagnostic approaches based on the detection and
quantization of urine metabolites.
By means of a 1H-NMR analysis, we were able to identify several metabolites whose concen-
trations were significantly higher in the urine samples of CT-positive subjects, including
sucrose, mannitol, pyruvate and lactate. These results were comparable for all the CT serovars
detected (D, E, F, G, K), thus indicating a common behaviour in presence of chlamydia, irre-
spective of the specific serovars.
At first, we hypothesized that a higher level of sucrose in the urethral lumen, related to a
higher sugar consumption, could have favored CT acquisition or delayed its clearance. Indeed,
it has been shown that urinary sucrose is a biomarker for total sugar consumption, considering
that the diet-intake of sucrose is significantly correlated with its concentration in urines [21,
22]. In this context, it has been demonstrated that sucrose can increase the stability of chla-
mydial proteins (i.e. MOMP: major outer membrane proteins), thus potentially leading to a
longer viability of CT elementary bodies [23].
In a similar way, mannitol, a sugar alcohol often found in hard candies, fruits and vegeta-
bles, could act as a ‘stabilizer’ of proteins and membranes, lengthening the bacterial viability
[24–26].
Second, we highlighted a significant difference in the concentration of 2-furoylglycine and
acetone between the study groups. It has been shown that 2-furoylglycine at the urinary level
can be considered as a biomarker of caffeine consumption [27] and, in addition, can derive
from furan derivatives found in food prepared by strong heating [28]. Contrariwise, the uri-
nary excretion rate of acetone, one of the ketone bodies, is found to be higher during fasting or
low-sugar diet [29].
Peculiar dietary habits of the subjects enrolled, in term of type and amount of food con-
sumed and presence of fasting periods, could probably explain these findings.
Finally, we supposed that the presence of higher levels of pyruvate and lactate in urines of
infected women could be ascribed to CT-induced immunopathology. Following CT uro-geni-
tal infection, an early acute inflammatory response occurs, characterized by secretion of pro-
inflammatory cytokines (TNF-α, IL-8, IL-1, GM-CSF) and recruitment of immune cells (mac-
rophages, CD4+ and CD8+ T cells, neutrophils) [30, 31]. A key feature of the inflammatory
microenvironment is the accumulation of lactate, a by-product of highly proliferating cells
during the glycolytic pathway [32, 33]. Indeed, it has been shown that, at the inflammatory
sites, a metabolic switch to aerobic glycolysis occurs in T lymphocytes. This change leads to
the up-regulation of glycolytic enzymes and glucose transporters to the membrane, with an
increase in glycolytic flux and the concomitant production of lactate, derived from the conver-
sion of pyruvate [32–34]. In this context metabolomics has been recently and successfully
employed to show that the accumulation of lactate is a marker of inflammation in several
organs and tissues [35–38].
We are fully aware that some limitations could have affected our study. At first, the lack of
information about the type and amount of leukocytes in the urethral fluids of patients made
any association between metabolic changes and inflammation impossible. Second, the avail-
ability of data about dietary habits or food consumption would have strengthened the metabo-
lomic results obtained. Even though the data presented here are mainly preliminary and
descriptive, this study can open the way to the use of new ‘omic’ sciences, as metabolomics, to
deepen host-pathogen interactions and to better understand C. trachomatis pathogenesis.
Chlamydia trachomatis and urine metabolome
PLOS ONE | https://doi.org/10.1371/journal.pone.0194827 March 22, 2018 8 / 11
Conclusions
To the best of our knowledge this is the first report investigating the urine metabolome in
women with CT uro-genital infection. We were able to identify several metabolites whose con-
centrations were significantly higher in the urine samples of CT-infected women. Further
studies are needed to understand the accurate origin of the urine metabolites and to compre-
hend if the observed alterations precede or follow the infection onset. Moreover, the potential
role of these metabolites in the pathogenesis of CT infection, as well as their diagnostic/prog-
nostic use, should be investigated.
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standard. The area under the peak of each molecule was calculated after the integration of the
signals by means of a rectangular integration.
(DOCX)
S1 Table. Concentration (mM) of urine metabolites determined by 1H-NMR. Results are
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